🇺🇸 FDA
Patent

US 7638543

Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

granted A61KA61K31/426A61K31/655

Quick answer

US patent 7638543 (Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof) held by The Regents of the University of California expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/426, A61K31/655, A61P, A61P43/00